openPR Logo
Press release

Colorcon, Inc. Introduces Opadry® 200 Optimized Performance Film Coatings

10-26-2011 02:52 PM CET | Health & Medicine

Press release from: Colorcon

HARLEYSVILLE, Pa., -- Colorcon, Inc. will introduce a new optimized performance film coating system, Opadry® 200, during the week of October 24, 2011 at both the American Association of Pharmaceutical Scientists Annual Meeting in Washington, D.C. (Booth #2237) and the CPhI Worldwide Event in Frankfurt, Germany (Stand #42J05). Opadry 200 represents Colorcon's continued innovation and leadership in ensuring a full line of functional options for pharmaceutical formulators.

Colorcon developed Opadry 200 in response to industry demand for continual improvement in performance and cost. According to Kamlesh Oza, General Manager of Film Coatings at Colorcon, "Pharmaceutical scientists today work with medications that have known sensitivity to light, moisture and oxygen. It has been a challenge to find a fully formulated product that can quickly coat those products in a cost effective manner and protect them. Our new system is an optimized performance, low tack, high-film strength, immediate release system that helps cut manufacturing time, and achieves best-in-class moisture protection along with superior product appearance."

Opadry 200 systems are designed using compendial ingredients that meet the regional and/or global regulatory requirements of the user when developing NCE, OTC or generic products.

Colorcon is a world leader in the development, supply and support of formulated products for the
pharmaceutical and nutritional industries. Its core businesses include film coatings, modified release
technologies, functional excipients and tablet design services. Colorcon has 18 technical service laboratories globally and more than 1200 employees exclusively dedicated to its customer base. For more information, visit http://www.colorcon.com.

Diane Reitter
Global Communication Director
Colorcon, Inc.
415 Moyer Blvd.
West Point, PA, 19486
215-661-2639
dreitter@colorcon.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Colorcon, Inc. Introduces Opadry® 200 Optimized Performance Film Coatings here

News-ID: 197864 • Views: …

More Releases from Colorcon

Colorcon and BASF Announce Collaboration to Develop Film Coating Applications Us …
Harleysville, PA, Ludwigshafen, Germany – Colorcon, Inc. and BASF have announced a collaboration for the development of future film coating systems using Kollicoat® Smartseal 30 D, and a new Colorcon pre-formulated additive. Colorcon has developed a pre-formulated additive system for use with Kollicoat Smartseal 30D which enables efficient preparation and application of this polymer in taste masking applications. The preformulated additive lowers the number of materials to be dispensed by 50%…

More Releases for Opadry

Pharmaceutical Excipient Market to Reach USD 1,600.0 Million by 2034 at a 5.1% o …
Future Market Insights (FMI) has released an updated analysis of the pharmaceutical excipient market, projecting steady growth over the next decade. The market is expected to be valued at US$ 972.9 million in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 5.1%, reaching a valuation of US$ 1.6 billion by 2034. The rising demand for innovative drug formulations, enhanced bioavailability, and advanced delivery systems…
US Pharmaceutical Excipient Market Booming Worldwide with Latest Trend and Futur …
The US pharmaceutical excipient market is estimated to grow at a CAGR of 7.9% during the forecast period. The presence of a well-established pharmaceutical industry in the country considerably contributes to the growth of the market. A rise in the generic drugs industry has been observed significantly. The generic drug manufacturers are dedicated to increasing the Abbreviated New Drug Application (ANDA) filings. They are adopting the business model that relies…
Enteric Coating Market Trends, Market Share, Industry Size, Growth, Opportunitie …
The global enteric coating market is anticipated to grow at a significant CAGR of 3.9% during the forecast period (2022-2028). Enteric coating is a beneficial method for oral delivery of medications that rapidly break down in the stomach, such as insulin, since it prevents the drug from being released in the stomach's acidic environment before reaching the intestine. The primary use of enteric coatings is to maintain the stability of…
Global Biologic Excipients Market 2028 | Industry Crucial Players - Roquette Frà …
Excipients are denoted as relevant pharmaceutical additives added to active pharmaceutical ingredients in sparse amounts to ensure superlative drug functionality. Extensive drug development initiatives coupled with significant progress in development of apt biological excipients translates growth in biological excipients market. In its recent business intelligence report titled, ‘Biologic Excipients Market: Global Industry Analysis 2013 – 2017 and Opportunity Assessment 2018 – 2028‘, Market Research Reports Search Engine (MRRSE) enumerates ongoing developments…